- Home
- TPST vs NYC Comparison
TPST vs NYC Comparison
Compare TPST & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- NYC
- Stock Information
- Founded
- TPST 2011
- NYC 2013
- Country
- TPST United States
- NYC United States
- Employees
- TPST N/A
- NYC N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- TPST Health Care
- NYC Finance
- Exchange
- TPST Nasdaq
- NYC Nasdaq
- Market Cap
- TPST 33.0M
- NYC 36.5M
- IPO Year
- TPST N/A
- NYC N/A
- Fundamental
- Price
- TPST $10.16
- NYC $11.89
- Analyst Decision
- TPST Hold
- NYC
- Analyst Count
- TPST 3
- NYC 0
- Target Price
- TPST $30.00
- NYC N/A
- AVG Volume (30 Days)
- TPST 111.5K
- NYC 1.4K
- Earning Date
- TPST 08-11-2025
- NYC 08-08-2025
- Dividend Yield
- TPST N/A
- NYC N/A
- EPS Growth
- TPST N/A
- NYC N/A
- EPS
- TPST N/A
- NYC N/A
- Revenue
- TPST N/A
- NYC $54,865,000.00
- Revenue This Year
- TPST N/A
- NYC $8.40
- Revenue Next Year
- TPST N/A
- NYC $1.62
- P/E Ratio
- TPST N/A
- NYC N/A
- Revenue Growth
- TPST N/A
- NYC N/A
- 52 Week Low
- TPST $5.35
- NYC $7.89
- 52 Week High
- TPST $20.67
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- TPST 72.60
- NYC 38.83
- Support Level
- TPST $6.96
- NYC $11.89
- Resistance Level
- TPST $10.90
- NYC $13.05
- Average True Range (ATR)
- TPST 0.63
- NYC 0.61
- MACD
- TPST 0.33
- NYC -0.17
- Stochastic Oscillator
- TPST 81.24
- NYC 0.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.